On May 15 – May 18, 2022, this poster was on display at ISPOR 2022.
What is the Objective of this Poster?
- Results provide insights into real-world treatment patterns for vitiligo
within a diverse set of US healthcare settings.
- Increased use of TCS and TCI coincided with decreased use of
- As new treatments are developed and introduced, future analyses would
be helpful to understand uptake of therapies and prescription patterns
among vitiligo patients
Register to view this poster now!